Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polyvinylpyrrolidone-coated silver nanoparticles are **silver nanoparticles stabilized with polyvinylpyrrolidone (PVP)**, a synthetic polymer. The PVP coating increases colloidal stability, prevents aggregation, and modifies biological interactions, making these nanoparticles suitable for **biomedical applications** such as wound care, drug delivery, and antimicrobial coatings. Their mechanism of action primarily involves the gradual release of silver ions from the nanoparticle surface, which exert **broad-spectrum antimicrobial effects** by disrupting bacterial membranes, interfering with respiration and cellular enzymes, and inducing oxidative stress, DNA damage, and cell death. PVP-AgNPs are also used in cancer therapy research for targeted delivery and cytotoxicity against tumor cells. The PVP coating is primarily functional and does not independently contribute to therapeutic activity but enhances nanoparticle properties such as dispersion and biocompatibility[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyvinylpyrrolidone-coated silver nanoparticles.